Azitredil

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Azitredil

Property Description
Active ingredient Azithromycin
Form Tablet, Suspension, IV Powder
Pharmacological Class Macrolide Antibiotic (Azalide Subclass)
Common Purpose Combatting bacterial infections
Origin Semi-synthetic
Legal Status Prescription Only (Rx)

Classification and Core Identity

Azitredil is a prescription-only medication that contains the active substance Azithromycin, which is classified as an antibiotic and specifically belongs to the Azalide subclass of Macrolide antibiotics. This classification confirms that the drug is designed to act against susceptible bacteria that cause infections, such as those responsible for respiratory tract issues.

Azithromycin is chemically derived from the Macrolide Erythromycin, making it a semi-synthetic compound. This modified structure grants it unique pharmacokinetic advantages. Azithromycin is characterized by high tissue penetration and a prolonged half-life, allowing it to remain active for an extended period, which often enables less frequent administration compared to older antibiotics in its class.

Composition and Available Preparations

The medication is fundamentally a single-ingredient product, formulated with the active substance Azithromycin (or its dihydrate salt) combined with inert pharmaceutical excipients. Its availability in multiple high-level dosage forms ensures flexibility in administration.

The most common preparations include the primary oral forms—the film-coated tablet and the oral suspension—intended for administration via the oral route. For specific clinical requirements, Azithromycin is also supplied as a lyophilized powder that is reconstituted using a sterile base/vehicle for subsequent delivery via the intravenous (IV) route.

General Purpose of Azithromycin

The general purpose of Azitredil is to assist the body in eliminating or controlling bacterial pathogens and to resolve the underlying infectious condition. It functions by binding to the 50S ribosomal subunit inside the bacterial cell, thereby interfering with the vital process of bacterial protein synthesis. This targeted mechanism prevents susceptible bacteria from multiplying and spreading, reducing the infectious load and supporting the body's natural recovery processes.

Regulatory References

  1. MedlinePlus Drug Information

What side effects are possible with Azitredil?

Possible Side Effects and Safety Information

Azitredil's safety profile, based on official regulatory documents, describes adverse reactions categorized by frequency and the body system affected. The most common adverse effects are concentrated in the Gastrointestinal Disorders System Organ Class.

Frequency and Systemic Effects

Side effects classified as Very Common (1/10) include diarrhoea and abdominal pain. Reactions reported as Common (1/100 to < 1/10) include nausea, vomiting, headache, and fatigue. Less frequent, Uncommon reactions include dizziness, somnolence, palpitations, and photosensitivity reaction.

Serious Safety Considerations

The prescribing information documents several serious adverse reactions, including the risk of QT interval prolongation, which may lead to Torsades de Pointes (a potentially fatal heart rhythm disorder). Cases of severe, sometimes fatal, hepatotoxicity (including hepatic necrosis and fulminant hepatitis) and serious allergic reactions like anaphylaxis and Stevens-Johnson Syndrome (SJS) have been reported. Clostridioides difficile-associated diarrhoea (CDAD) is also a documented serious complication.

Population-Specific and Contextual Notes

Specific regulatory caution is advised for patients with severe renal impairment (GFR <10 mL/min) and those with significant hepatic disease. The label notes an increased risk of acute cardiovascular death was observed during the first five days of use in some studies, and that CDAD can occur up to two months after administration. Furthermore, use is generally restricted in individuals with a prior history of cholestatic jaundice or hepatic dysfunction associated with Azithromycin.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents state that an overdose of Azitredil (Azithromycin) typically presents with an exaggeration of known effects. The most frequently documented manifestations in regulatory texts are nausea, vomiting, diarrhea, and stomach discomfort. A specific severe manifestation associated with macrolide overdose noted in official labeling is the potential for reversible loss of hearing.

Immediate Emergency Actions

It is officially required to seek immediate medical attention at the first suspicion of an overdose. Contact with the local poison control center or emergency medical services is warranted. Regulators stress the need to immediately call emergency services if the person has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened.

Official Management and Monitoring

The official procedure for managing an overdose is constrained by the fact that no specific antidote is known for Azithromycin. Management is focused entirely on providing general symptomatic treatment and supportive measures. Administration of medicinal charcoal may be indicated as part of the documented procedure. Where necessary, measures to support vital functions and hospital monitoring are required for serious cases.

Therapeutic Uses of Azitredil

What Azitredil Treats: Main Uses and Benefits

The therapeutic role of Azitredil (Azithromycin) is relevant across multiple medical domains. The medication is commonly used to help with symptoms linked to organ-specific functional stress, contributing to easing the overall symptom load.

Azitredil is primarily applied across conditions presenting with acute bacterial episodes, including infections of the respiratory tract (such as pneumonia and sinusitis), the ear (otitis media), and specific uncomplicated skin and sexually transmitted infections. This use plays a role in managing symptom clusters that create noticeable physiological strain, such as persistent cough, fever, localized pain, and discharge.

In clinical settings that involve acute or unstable symptom patterns, the medication is considered relevant when short-term symptomatic assistance is needed. This includes management during acute bacterial exacerbations of chronic conditions like COPD. Its use contributes to improved comfort during symptomatic periods and may assist with maintaining functional stability.


Quick Facts

Quick Fact: Relief for Acute Discomfort Azitredil provides supportive relief in scenarios where symptoms become temporarily overwhelming, helping patients cope more steadily with symptom fluctuations associated with bacterial infections.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Azitredil?

The population eligibility for Azitredil (Azithromycin) is strictly defined by regulatory documents, which establish clear restrictions, contraindications, and age limitations.


Contraindicated Populations

  • Patients with known hypersensitivity to azithromycin, erythromycin, or any macrolide or ketolide drug.
  • Patients with a history of cholestatic jaundice or hepatic dysfunction associated with prior azithromycin use.

Age-Related and Condition-Specific Restrictions

Population Group Regulatory Status and Limitation
Infants under 6 months Safety and effectiveness have not been established for most uses.
Neonates (up to 42 days) Specific warning regarding risk of Infantile Hypertrophic Pyloric Stenosis (IHPS).
Severe Renal Impairment Use requires caution ( GFR < 10 mL/ min).
Hepatic Impairment Use requires caution as pharmacokinetics are not established.
Cardiovascular Conditions Use requires caution in patients with QT prolongation or Torsades de Pointes history.

Pregnancy and Lactation Eligibility

Use during pregnancy is permitted only if clearly needed and the benefit is determined to outweigh the potential risk. Caution must be exercised when administering to a nursing mother, as stated in official labeling.

What should I know about interactions with other medicines?

Azitredil is a macrolide antibiotic with a moderate potential for drug-drug interactions. It is essential to inform your healthcare provider about all prescription and non-prescription medicines, supplements, and herbal products you are currently taking.

Potential Major Interactions

Co-administration of Azitredil with certain medications can increase the risk of serious side effects, including QT interval prolongation, which may lead to life-threatening heart rhythm issues such as Torsades de Pointes. Medications that increase this risk include:

  • Antiarrhythmics: such as amiodarone.
  • Antipsychotics: such as pimozide.
  • Antidepressants: such as citalopram.

Other Significant Interactions

Interacting Drug Class Potential Effect and Management
Anticoagulants (e.g., Warfarin) Azitredil may enhance the effect of anticoagulants, increasing the risk of bleeding. Close monitoring of International Normalized Ratio (INR) is recommended.
Digoxin Azitredil may increase digoxin levels, leading to toxicity. Monitoring of digoxin levels is necessary.
Colchicine Increased exposure to colchicine can occur, raising the risk of severe side effects.
Antacids (containing aluminum or magnesium) Antacids can significantly decrease the absorption of Azitredil when taken at the same time, making it less effective. Separate the dosing of Azitredil and antacids by at least two hours.

Consult your doctor or pharmacist if you have concerns about potential drug interactions.

Mechanism of Action

Targeted Inhibition of Bacterial Protein Synthesis

Azitredil (Azithromycin) exerts its primary effect by targeting the 50S ribosomal subunit of susceptible bacteria, specifically inhibiting the bacterial translation pathway. By physically blocking the nascent peptide exit tunnel of the ribosome , the drug prevents bacteria from building essential proteins, leading to a state of bacteriostasis and halting bacterial growth and replication.


️ Modulation of Host Inflammatory Signaling

The drug also possesses a distinct, non-antimicrobial mechanism by influencing the host immune system. Azithromycin concentrates within immune cells and acts as a modulator by decreasing the release of pro-inflammatory cytokines (like IL-8) and reducing neutrophil migration to the site of infection. This action results in decreased neutrophil infiltration and reduces the expression of inflammatory mediators at the tissue level.


Mechanistic Constraints and Override

The function of this mechanism is constrained by bacterial interference. Certain bacteria can express efflux pumps that actively pump the drug out of the cell, or they can enzymatically modify the 23S rRNA target, reducing the drug's binding affinity. These mechanisms result in a failure to inhibit protein synthesis, leading to unhindered bacterial replication.

Dosage and Administration Information

How to Use Azitredil (Azithromycin): Administration Guidelines

Proper use of Azitredil involves adherence to specific routes, dosing, and administration conditions.

Administration Scope

Feature Instruction
Route of Administration Oral (tablets, suspensions) and Intravenous (IV) infusion only.
Standard Dosing Schedule Typically 500 mg on Day 1, followed by 250 mg once daily on Days 2–5. Alternatives include a 500 mg once daily 3-day course, or a single 1 gram dose.
Timing in Relation to Meals Tablets and standard suspensions may be taken with or without food. Extended-release oral suspension must be taken on an empty stomach.

Preparation and Special Conditions

Preparation requirements:

  • Oral Suspension: Powder packets require mixing with a specific volume of water (e.g., 60 mL) and must be consumed immediately and completely.
  • IV Infusion: The powder must be reconstituted and then diluted in an appropriate IV fluid to a final concentration of 1 mg/mL or 2 mg/mL.

Special Procedural Conditions:

  • IV Administration: Must be given as a slow infusion; a 1 mg/mL solution must be infused over 3 hours, and a 2 mg/mL solution over 1 hour. The drug must not be given as a bolus or intramuscular injection.

Age-Group Administration:

  • Pediatric dosing requires calculation based on the child's body weight (mg/kg). The 1 gram single-dose oral suspension is not approved for pediatric use.

Missed Dose Rule:

  • If a dose is missed, take it as soon as it is remembered. If it is close to the next scheduled dose, skip the missed dose and resume the regular schedule. Do not take a double dose.

This structured administration protocol ensures adherence to specific frequency, dose, and preparation standards.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Azitredil

Evidence for Acute Respiratory and Ear Infections

Research for Azitredil has examined evidence structures for clinical situations such as community-acquired pneumonia, acute bacterial sinusitis, and acute exacerbations of chronic bronchitis, as well as acute otitis media (ear infection). These evaluations typically included short-term randomized controlled trials (RCTs).

Studies focused on outcomes that included measurements related to the clearance of targeted bacteria and the evaluation of short-term symptom patterns. Research examined outcomes related to physical discomfort and how systemic or functional imbalance was monitored within the observed patient populations. A key limitation noted is that research primarily studied patients with mild to moderate conditions, with limited information available for those requiring non-oral treatment.


Evidence for Uncomplicated Sexually Transmitted Infections

Research for Azitredil has examined evidence structures for clinical situations such as uncomplicated infections of the urethra or cervix. The studies monitored the microbiological cure rate, which is a key outcome, documenting the clearance of specific bacterial pathogens. Data show patterns related to measurements of treatment response in different parts of the body. Limited information exists regarding the outcome in infections located in certain sites, such as the rectum.


Long-Term Studies and Follow-up Durations

Research has explored the evidence structure related to Azitredil in conditions characterized by fluctuating or episodic manifestations, such as COPD or bronchiectasis. These long-term studies monitored specific outcomes such as the frequency of acute episodes (or flare-ups) that occurred during the observation period. Uncertainty remains regarding long-term outcomes, which are not well characterized. Research data show patterns related to an increased incidence of macrolide-resistant bacteria observed with prolonged use, which is a documented limitation.

Frequently Asked Questions (FAQ)

Common questions about Azitredil (FAQ)


Q: How quickly should I expect Azitredil to start working?

Official product information indicates that Azitredil is characterized by a prolonged half-life, meaning the medicine stays in the body's tissues for a long period. This characteristic allows it to be prescribed in short courses with infrequent doses. The concentration that fights the infection builds up and remains active for several days after the last dose is taken.


Q: Are there specific foods or drinks I should avoid while using Azitredil?

The tablets and standard oral suspension formulations can generally be taken with or without food. However, the extended-release suspension must be taken on an empty stomach to ensure proper absorption. Additionally, official documents state that antacids containing aluminum or magnesium should be separated from Azitredil by at least two hours to prevent decreased absorption.


Q: Does Azitredil have a long-term effect on my body after I stop taking it?

Due to its high tissue concentration and prolonged half-life, the active substance can remain detectable in your body for several days after completing the prescribed course. Studies on prolonged, non-daily use have indicated an increased risk of promoting macrolide-resistant bacteria, which is a key consideration documented in long-term safety information.


Q: Why does Azitredil have to be stored at a certain temperature?

Azitredil must be stored at the controlled room temperatures listed on the label and protected from excess heat and moisture. According to official guidelines, this ensures the product maintains its stability and effectiveness throughout the labeled shelf life. Specific liquid and reconstituted forms may also have short expiration times or unique temperature requirements after mixing.


Q: Are there limitations on how long Azitredil can be taken safely?

Treatment courses for acute infections are typically short, often lasting between 3 and 5 days, as outlined in the administration protocol. Studies on long-term use for chronic inflammatory conditions are monitored closely because prolonged exposure has been linked to an increased risk of bacterial resistance.


Q: Is Azitredil safe for women who might become pregnant?

Regulatory documents state that use during pregnancy is permitted only if it is clearly needed and the potential benefit is determined to outweigh the risk. Caution is also advised when the medicine is administered to a nursing mother. Official information indicates that decisions regarding use when planning a pregnancy are best addressed by a healthcare professional.


Q: Does the effectiveness of Azitredil change over time?

Official research evidence indicates that one of the limitations of Azitredil is the potential for decreased effectiveness over time with prolonged or inappropriate use. This is associated with an increased incidence of macrolide-resistant bacteria, which can learn to circumvent the drug's mechanism of action.


Q: Why do some people take Azitredil for conditions that aren't its main use?

Azitredil (Azithromycin) is classified as an antibiotic, but its mechanism of action is understood to include a distinct non-antimicrobial function. This second action involves immunomodulatory or anti-inflammatory effects by reducing certain pro-inflammatory substances in the body. This characteristic is the basis for its investigation in managing various inflammatory conditions outside its primary infectious uses.


Q: If I miss multiple doses of Azitredil, what is the usual guidance?

The official instructions provide clear guidance only for the instance of a single missed dose. However, if multiple doses are missed, regulatory guidelines suggest that the prescribing doctor be contacted. This is necessary to ensure the treatment course remains effective and to prevent potential resistance issues.


Q: Are there different strengths or versions of Azitredil available?

Yes, the active substance Azithromycin is available in several versions to accommodate different needs and patient populations. These forms include oral tablets, a standard oral suspension, an extended-release suspension, and a powder that is prepared for intravenous (IV) infusion.


Q: Do studies suggest Azitredil is generally well-tolerated?

The overall safety profile documented in regulatory sources shows Azitredil is generally considered to be well-tolerated in many populations. The most common side effects are concentrated in the digestive system, although the official prescribing information also details rare but serious adverse reactions that have been reported.


Q: Is Azitredil the same kind of medicine as other common treatments for this condition?

Azitredil's active ingredient, Azithromycin, is classified as a macrolide antibiotic of the azalide subclass. This makes it chemically related to, but distinct from, other types of antibiotics, such as penicillins or cephalosporins, which may also be used to treat similar bacterial infections.


Q: Is Azitredil known to cause weight changes?

Weight changes are generally not listed among the common side effects of Azitredil. However, some post-market reports have included changes in appetite that may lead to weight gain or loss, though these are considered uncommon occurrences.


Q: Are there any specific safety warnings for older adults taking Azitredil?

While a dose adjustment is typically not required for elderly patients, official product information recommends particular caution in this population. This caution relates to the slightly increased risk of developing cardiac rhythm issues, such as Torsades de Pointes, in older patients.


Q: I'm taking an over-the-counter pain reliever. Is that safe with Azitredil?

The official drug interaction list is comprehensive regarding prescription medications, but it does not typically list specific interactions with common non-steroidal, over-the-counter pain relievers. It is recommended that individuals inform their prescribing doctor or pharmacist about all prescription and non-prescription medicines being taken.


Q: Is Azitredil considered a controlled substance?

No, official regulatory authorities classify Azitredil as a Prescription Only (Rx) medicine. It is not listed as a controlled substance by the US Drug Enforcement Administration or equivalent global regulatory bodies.


Q: Can I take Azitredil with my daily vitamin supplements?

Official product information indicates that there is generally not enough formal clinical data available from trials to confirm the safety of combining Azitredil with all complementary medicines, herbal remedies, or supplements. It is generally advised to disclose all supplements to your prescribing doctor or pharmacist.


Q: Does Azitredil interact with alcohol consumption?

Regulatory documents do not specifically list a severe interaction between Azitredil and alcohol. However, since alcohol can sometimes increase common side effects like nausea and dizziness, it is prudent to be cautious and to consider temporary avoidance during the short treatment course.


Q: What are the signs that Azitredil might not be working for me?

If the symptoms of your infection do not improve within a few days of starting the treatment, or if the symptoms worsen, this may be a sign that the drug is not fully effective. Furthermore, the official label warns that failing to complete the full course as prescribed can reduce the drug's effectiveness.


Q: Are there any known interactions with herbal supplements like St. John's Wort?

The overall safety of combining prescription medicine with herbal supplements, including St. John's Wort, is not fully established through clinical trials. It is important for individuals to disclose all herbal supplements being used to their healthcare team, as they may affect how Azitredil or other medications are processed by the body.


Q: Does Azitredil cause dry mouth or changes in taste?

Dry mouth and an altered sense of taste are documented as possible adverse effects in official prescribing information. These side effects are generally classified as uncommon in frequency.


Q: What kind of research is currently being done on Azitredil?

Official clinical trial registries show that research on Azitredil remains ongoing, often focused on its impact in high-risk populations and global health. For instance, current Phase 4 trials are investigating its effectiveness in reducing child mortality and studying the drug’s overall impact on antibiotic resistance patterns.


Q: What should I do if the side effects of Azitredil feel bothersome but not severe?

If side effects become bothersome but are not serious (like minor headache or fatigue), it is recommended that you inform your doctor or pharmacist. However, official guidance advises stopping the medication and seeking urgent medical attention immediately for any serious or severe reactions, such as signs of liver damage, an allergic reaction, or difficulty breathing.


Q: Can Azitredil interfere with birth control pills?

Some antibiotics, including Azitredil, may potentially reduce the effectiveness of combined oral contraceptives (birth control pills) in certain individuals. This may increase the risk of breakthrough bleeding or unintended pregnancy. Individuals using this combination are advised to consult their healthcare provider for individualized guidance.


Q: Can Azitredil affect blood sugar levels?

Azitredil itself is not listed to directly affect blood glucose. However, the oral suspension formulation may contain sucrose as a pharmaceutical excipient. Official warnings state that diabetic patients and those with known sugar intolerances should exercise caution when using this specific formulation.


Q: Is Azitredil available as a generic medicine?

Yes, the active ingredient in Azitredil, Azithromycin, is widely available as a generic medication. This is noted in approved drug product lists published by government health authorities.

How should Azitredil be stored and disposed of?

How to Store and Dispose of Azitredil (Azithromycin)

The storage and disposal of Azitredil must adhere strictly to regulatory requirements to ensure product stability.

Storage Conditions

Azithromycin tablets and dry powder must be stored at controlled room temperature, generally between 59 F and 86 F (15 C to 30 C), and protected from excess heat and moisture. The original container must be kept tightly closed and stored out of the sight and reach of children.

Stability and Handling

Storage rules vary by preparation type:

  • Multi-Dose Oral Suspension: Must be discarded after 10 days of reconstitution.
  • Single-Dose Oral Suspension: Must not be refrigerated and must be discarded after 12 hours.

Disposal Instructions

Any unused, expired, or leftover Azithromycin must be thrown away safely. Disposal must follow official guidelines, such as those recommended by the FDA, when the medication is no longer needed.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Azitredil found in:

A-Z Index: